...
机译:先前肝脏移植的高血清可溶性CD40L水平与肝细胞癌患者的肝移植有关的死亡率有关
Intensive Care Unit Hospital Universitario de Canarias;
Intensive Care Unit Hospital Universitario Nuestra Se?ora Candelaria;
Department of Surgery Hospital Universitario Nuestra Se?ora de Candelaria;
Laboratory Department Hospital Universitario de Canarias;
Department of Surgery Hospital Universitario Nuestra Se?ora de Candelaria;
Department of Digestive Hospital Universitario Nuestra Se?ora de Candelaria;
Department of Digestive Hospital Universitario Nuestra Se?ora de Candelaria;
Intensive Care Unit Hospital Universitario Nuestra Se?ora Candelaria;
Research Unit Hospital Universitario de Canarias;
Department of Surgery Hospital Universitario Nuestra Se?ora de Candelaria;
Soluble CD40L; Hepatocellular carcinoma; Liver transplantation; Mortality; Outcome;
机译:对肝细胞癌患者之前以肝癌患者肝移植的响应“高血清可溶性CD40L水平与一年的死亡率相关:方法论问题”
机译:先前肝脏移植的高血清可溶性CD40L水平与肝细胞癌患者的肝移植有关的死亡率有关
机译:在肝移植后肝移植前肝细胞癌的高血清Caspase-3水平,肝移植后的第一年性能高
机译:人工神经网络模型可预测肝细胞癌术后5年死亡率,并与Logistic回归模型进行性能比较:全国台湾数据库研究
机译:质子治疗后血清α甲胎蛋白和维生素K拮抗剂II水平诱导的蛋白的短暂增加不一定表明肝细胞癌的进展
机译:肝癌肝移植之前血清P含量高的患者发生一年肝移植死亡率的风险更高
机译:在肝细胞癌患者患者患有患者肝移植后的预先体验血清可溶性PD-1水平和预后的关联。